STOCKSCREENR

MTNB

AMEX

Matinas BioPharma Holdings, Inc.

$0.70+0.05(+7.47%)Mkt Cap: $3.88M

Key Stats

Market Cap

$3.88M

P/E Ratio

-0.35

EPS

$-2.00

Dividend Yield

0.00%

52-Week Range

$0.48 — $3.09

Volume

33.36K

Avg Volume

27.33K

Beta

1.40

Price Alerts for MTNB

Get alerted when MTNB hits your target price.

$

Free — enter your email to get started

Valuation

P/E (TTM)

-0.35

Forward P/E

—

PEG Ratio

-0.01

P/S (TTM)

0.00

P/B (TTM)

0.62

P/FCF

—

EV/EBITDA

—

EV/Sales

—

Financial Health

ROE (TTM)

-1.74%

ROA (TTM)

-1.52%

ROIC

—

Gross Margin

0.00%

Operating Margin

0.00%

Net Margin

—

Debt/Equity

0.28

Current Ratio

2.79

Growth

EPS Growth (YoY)

—

Revenue Growth (YoY)

—

EPS Growth (3Y)

-0.10%

EPS Growth (5Y)

-0.05%

Sales Growth (3Y)

+31.32%

Sales Growth (5Y)

+18.78%

EPS Est (This Year)

$-5.00

EPS Est (Next Year)

$-2.50

Dividends

Dividend Yield

—

Annual Dividend

—

Payout Ratio

—

Frequency

—

Ex-Dividend Date

—

Cash/Share

$0.73

Ownership

Institutional %

—

Inst. Net Change

—

Insider Net Shares (90d)

—

Outstanding Shares

5.55M

Float

4.38M

Free Float %

78.89%

About

Sector

Healthcare

Industry

Biotechnology

Country

US

Exchange

AMEX

IPO Date

2014-07-21

Employees

3

CEO

Jerome D. Jabbour

Index Membership

—

Website

https://www.matinasbiopharma.com

Matinas BioPharma Holdings, Inc. (MTNB) is a healthcare company in the biotechnology industry listed on the AMEX. With a market capitalization of $3.88M, a P/E ratio of -0.35, MTNB is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare MTNB against other stocks using dozens of fundamental and technical filters.

Similar Stocks

IBO.V

Universal Ibogaine Inc.

$0.01

-50.00%

$1.56M

AEON

AEON Biopharma, Inc.

$0.89

-3.58%

$10.53M

AIM

AIM ImmunoTech Inc.

$0.52

-0.64%

$1.75M

AZTR

Azitra, Inc.

$0.25

+0.45%

$2.66M

NFX.L

Nuformix plc

$0.17

+0.00%

$3.59M

PHIO

Phio Pharmaceuticals Corp.

$1.14

-6.56%

$13.24M

Frequently Asked Questions

What is Matinas BioPharma Holdings, Inc.'s P/E ratio?

Matinas BioPharma Holdings, Inc. (MTNB) has a trailing twelve-month (TTM) P/E ratio of -0.35. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.

Does Matinas BioPharma Holdings, Inc. pay a dividend?

No, Matinas BioPharma Holdings, Inc. (MTNB) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.

What is Matinas BioPharma Holdings, Inc.'s market cap?

Matinas BioPharma Holdings, Inc. (MTNB) has a market capitalization of $3.88 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.